Table 3.
Estimated adjusted effects of variables on mean femoral neck BMD at baseline and BMD change over 4.3 years follow-up (n = 753 patients, 1166 visits)
Variable | Estimated effect | 95% CI | P value |
---|---|---|---|
Mean difference of BMD at baseline | |||
Age at baseline (y) | -0.0037 | -0.0044to-0.0029 | < 0.0001 |
Gender | |||
Men | Ref. | < 0.0001 | |
Premenopausal women at baseline | -0.0481 | -0.0833to-0.0130 | |
Postmenopausal women | -0.0849 | -0.1082to-0.0617 | |
BMI at baseline (kg/m2) | |||
<25 | Ref. | < 0.0001 | |
≥25 | 0.0894 | 0.0703to0.1086 | |
Ethnicity | |||
No African origin | Ref. | < 0.0001 | |
African origin | 0.0746 | 0.0486to0.1008 | |
Tobacco use at baseline | |||
Never smoking | Ref. | 0.060 | |
Former smoker | -0.0036 | -0.0254 to 0.0179 | |
Current smoker | -0.0341 | -0.0626to-0.0059 | |
CKD stages at baseline | |||
1-2 | Ref. | < 0.01 | |
3a | -0.0171 | -0.0458 to 0.0113 | |
3b | -0.0313 | -0.0598to-0.0030 | |
4-5 | -0.0575 | -0.0894to-0.0257 | |
log(PTH) at baseline | -0.0230 | -0.0391to-0.0069 | < 0.01 |
Mean BMD change | |||
Time (yrs) | -0.0023 | -0.0127 to 0.0082 | 0.677 |
BMI at baseline (kg/m2) | |||
<25 | Ref. | <0.05 | |
≥25 | 0.0031 | 0.0002to0.0060 | |
CKD stages at baseline | |||
1-2 | Ref. | 0.099 | |
3a | -0.0014 | -0.0066 to 0.0037 | |
3b | -0.0045 | -0.0096 to 0.0005 | |
4-5 | -0.0004 | -0.0060 to 0.0052 | |
log(PTH) at baseline | -0.0005 | -0.0032 to 0.0022 | 0.704 |
BMD, bone mineral density; BMI, body mass index; CI, confidence interval; CKD, chronic kidney disease; PTH: parathyroid hormone.
The factor center has been included as random effect